Table 1 Patients characteristics
From: CD4+lymphocyte adenosine triphosphate - a new marker in sepsis with acute kidney injury?
Total | no AKI | AKIN 1 | AKIN 2 | AKIN 3 | p-value | |
|---|---|---|---|---|---|---|
n | 33 | 11 | 8 | 4 | 10 | |
Age | 66.15 (±16.42) | 60.09 (±16.77) | 74 (±12.98) | 80.25 (±6.75) | 60.9 (±16.79) | 0.054 n.s. |
Gender | ||||||
male | 20/33 (%) | 6/11 | 5/8 | 2/4 | 7/10 | 0.86 |
female | 13/33 | 5/11 | 3/8 | 2/4 | 3/10 | n.s. |
BMI | 30.05 (±7.5) | 28.43 (±7.89) | 31.11 (±9.93) | 26.03 (±1.38) | 32.36 (±6.57) | 0.467 n.s. |
SAPS at admission | 36.06 (±10.77) | 28.09 (±6.89) | 38.71 (±11.21) | 42 (±7.07) | 40.6 (±11.18) | 0.016 |
SAPS max | 39.32 (±10.65) | 32.73 (±9.45) | 42 (±7.75) | 43.25 (±6.5) | 43.4 (±12.17) | 0.077 n.s. |
Microbiology positiv | 11/33 | 4/11 | 0/8 | 4/4 | 6/10 | <0.01 |
Vasopressor therapy | 11/33 | 3/11 | 4/8 | 0/4 | 4/10 | 0.33 |
Survivor | 27/33 | 11/11 | 7/8 | 3/4 | 6/10 | 0.11 |
Comorbidities | ||||||
liver failure | 3/33 | 0/11 | 0/8 | 0/4 | 3/10 | 0.085 |
diabetes mellitus | 11/33 | 2/11 | 4/8 | 1/4 | 5/10 | 0.39 |
hypertension | 13/33 | 2/11 | 5/8 | 1/4 | 5/10 | |
CKD | 8/33 | 0/11 | 3/8 | 1/4 | 4/10 | 0.077 |
baseline eGFR (ml/min/1.73 m 2 | 73.29 ± 47.01 | 118.66 ± 27.5 | 39.73 ± 11.9 | 40.77 ± 19.37 | 34.8 ± 31.16 | <0.01 |
Discharge | ||||||
eGFR | 73.29 (±47.01) | 118.66 (±27.5) | 39.73 (±11.9) | 40.77 (±19.37) | 34.8 (±31.16) | <0.01 |
death | 6/33 | 0/11 | 1/8 | 1/4 | 4/10 | |
dialysis dependency | 1/33 | 0/11 | 0/8 | 0/4 | 1/10 | |
complete renal recovery | 14/33 | 11/11 | 1/8 | 1/4 | 1/10 | <0.001 |
partial renal recovery | 12/33 | 0/11 | 6/8 | 2/4 | 4/10 |